Skeptical Science New Research for Week #7 2024
Open access notables Physics-based early warning signal shows that AMOC is on tipping course, van Westen et al., Science Advances:
Source: skepticalscience.com
📰 Longitudinal Analysis News
Longitudinal Analysis News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Longitudinal Analysis. Real-time updates on events, politics, business and more.
Owners prove astute observers of asthma signs in horses - study
Veterinarians could leverage the feedback from owners, who have observed their horses over time, to assist them in making a diagnosis.
Source: horsetalk.co.nz
iFR and FFR are equally safe to diagnose and treat heart disease according to largest-ever analysis of new real-world, long-term data
Philips iFR iFR co-registration October 26, 2023 Safety of Philips’ iFR in the guidance of percutaneous coronary intervention (PCI) for heart disease demonstrated in late-breaking science at TCT 2023 highlighting patient-level outcomes analysis of 42,000 patients from the National Swedeheart Quality RegistryPrevious data demonstrate that iFR delivers consistent patient outcomes, reduces discomfort and offers a more cost-effective and faster diagnostic solution [1,2] compared to FFR Amster...
Source: yahoo.com
TXST study shows veterans experience more health issues
U.S. military veterans historically suffer worse overall health than other Americans.[San Marcos, TX] [Hays County news] News San Marcos News, San Marcos Record [Texas State]
United States Ramalingam Shanmugam Dianem Dolezel Paula Stigler Granados Gerardoj Pacheco Lawrencev Fulton
Source: sanmarcosrecord.com
Data from Across Incyte's Oncology Portfolio Accepted for Presentation at the 2023 ASCO Annual Meeting and EHA2023 Hybrid Congress
Incyte today announced that multiple abstracts featuring data from across its oncology portfolio will be presented at the upcoming 2023 American Society of Clinical Oncology Annual Meeting held... | May 25, 2023
Source: marketscreener.com
Data from Across Incyte's Oncology Portfolio Accepted for Presentation at the 2023 ASCO Annual Meeting and EHA2023 Hybrid Congress
Incyte (Nasdaq:INCY) today announced that multiple abstracts featuring data from across its oncology portfolio will be presented at the upcoming 2023 American Society of Clinical Oncology (ASCO) Annual
Source: finanznachrichten.de
"Taking the long view of the multinational" by André Sammartino, David Merrett et al.
Purpose: This paper argues for the benefits to international business (IB) of taking a much longer view at the engagement by multinational enterprises (MNEs) with host locations. Design/methodology/approach: The authors showcase a project tracking the engagement by MNEs with Australia over the past two centuries. Extensive archival work has been undertaken to identify and document modes of entry, home countries, industries, operational modes and company types among the MNEs operating in Australi...
Business History Foreign Direct Investment Ree Standing Companies Longitudinal Analysis Multinational Enterprises Perational Modes
Source: uow.edu.au
Miniature Avatars Take on NASA's Biggest Challenge | Science ...
2019 University of Pennsylvania/Children’s Hospital of Philadelphia’s lung-bone marrow chip.Science fiction or reality? Before traveling to Mars, NASA needs
Source: inferse.com
Analyzing electronic medical records to identify COVID-19 sequelae
In a recent study published in the journal Emerging Infectious Diseases, researchers analyzed and compared pre‒ and post‒COVID-19 diagnostic codes to identify symptoms that had higher encounter incidence in the post‒COVID-19 period as sequelae. COVID-19 sequelae and future emerging diseases can be generated and monitored using this method.
United States Emerging Infectious Diseases Longitudinal Analysis Electronic Health Information Identify Possible Image Credit
Source: news-medical.net
More than 50 Abstracts from Incyte's Robust Oncology Portfolio to be Featured at the 64th ASH Annual Meeting
- Plenary Scientific Session to highlight Incyte-discovered novel anti-mutant CALR-targeted monoclonal antibody INCA033989 - Data from three of the Company's LIMBER studies evaluating ruxolitinib
United States United Kingdom Catalina Loveman Ponatinib Iclusig Peter Langmuir Bendamustine Rituximab
Source: finanznachrichten.de